
zzso of zzso zzso can result in zzso zzso a severe neurodegenerative disease characterized by massive zzso storage of zzso zzso in the zzso Currently there are no available therapies that can even slow the progression of this zzso zzso enhancement therapy zzso small molecules that can often cross the blood brain barrier, but are also often competitive zzso of their target zzso It is a promising new approach for treating diseases, often caused by zzso zzso associated with dramatically reduced levels of functionally folded zzso Despite a number of positive reports based on zzso performed with patient cells, skepticism persists that an zzso treatment can increase zzso zzso activity in zzso To date no appropriate animal model, zzso one that zzso a responsive human zzso and clinical zzso has been reported that could be used to validate zzso enhancement zzso In this report, we identify a novel zzso zzso zzso that enhances the zzso zzso activity in the zzso of a number of patient cell lines containing a variety of zzso zzso We then demonstrate that treatment of cells from a previously zzso naturally occurring zzso model zzso zzso clinically and zzso closely mimics zzso zzso in zzso with this zzso results in a robust enhancement of their zzso zzso zzso zzso These data indicate that the zzso model could be used to validate this therapeutic approach and determine the relationship between the disease stage at which this therapy is initiated and the maximum clinical benefits zzso 

